marijuana stocks news

Inergetics, Inc. (NRTI)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 558   430   524   480  
Cost of Revenue 438 360 310 363
Gross Profit 120   70   213   117  
Operating Expenses
Research Development 0 11 9 4
Selling General and Administrative 1,430 1,294 1,556 3,141
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss (1,310) (1,235) (1,351) (3,028)
Income from Continuing Operations
Total Other Income/Expenses Net 3,245 (3,190) 509 (1,132)
Earnings Before Interest And Taxes 1,935 (4,425) (842) (4,160)
Interest Expense 241 (8) 401 367
Income Before Tax 1,694 (4,417) (1,243) (4,527)
Income Tax Expense (376) 2
Minority Interest
Net Income From Continuing Ops 1,875 (4,418) (1,240) (4,511)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income 2,070   (4,418) (1,243) (4,527)
Preferred Stock And Other Adjustments (332) (459) (322) (258)
Net Income Applicable To Common Shares 1,738   (4,878) (1,564) (4,785)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$RMHB Founder, Jerry Grisaffi, Discusses Current Events

Rocky Mountain High Brands Founder, Jerry Grisaffi, Discusses Current Events and Recent…

$PMCB Appoints American Stock Transfer as New Stock Transfer Agent

PharmaCyte Biotech Appoints American Stock Transfer as New Stock Transfer Agent PharmaCyte…

Dragonfly Therapeutics Announces AbbVie (ABBV) Opt-In of TriNKET™ Immunotherapy Drug Candidate

Dragonfly Therapeutics Announces AbbVie Opt-In of TriNKET™ Immunotherapy Drug Candidate Dragonfly Therapeutics…